No.4
公告
2026/10/22 13:00
事業の状況
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON COMMERCIALISATION OF CORE PRODUCT YOCHANRA
📄 打开公告原文
删除
No.3
公告
2026/09/21 21:07
中間報告書
INTERIM REPORT 2026
📄 打开公告原文
删除
No.2
公告
2026/09/18 19:50
事業の状況
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE II CLINICAL TRIAL OF TINENGOTINIB IN COMBINATION WITH NOVEL HORMONAL THERAPY FOR PRETREATED AND PROGRESSED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CHINA
📄 打开公告原文
删除
No.1
公告
2026/09/18 19:44
事業の状況
VOLUNTARY ANNOUNCEMENT INCLUSION OF YOCHANRA (TINENGOTINIB) IN THE CSCO GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF BILIARY TRACT CANCERS (2026)
📄 打开公告原文
删除